1.
PROGNOSIS OF NASOPHARYNGEAL CANCER,
MULTIVARIATE ANALYSIS OF FACTORS INFLUENCING THE OVERALL SURVIVAL. J.M., Nabholtz* (1), N. Jha (1), M. Al-Ahwal
(1), E. Rapp (2), C. Smith (2), Head and Neck Oncology Group of Alberta (1)
Cross Cancer Institute, Edmonton, (2) Tom Baker Cancer Center, Calgary, Alberta, Canada. Alberta
Cancer Board Scientific Retreat, 29th Nov – 1st Dec,
1991; Abstract.
2.
TREATMENT OUTCOME PREDICTIBILITY IN
NASOPHARYNGEAL CANCER, DISCREPANCY BETWEEN TAND N CLASSIFICATIONS. M. Al-Ahwal* (1), N. Jha (1), J.M., Nabholtz
(1), E. Rapp (2), C. Smith (2), Head and
Neck Oncology Group of Alberta (1) Cross Cancer Institute, Edmonoton, (2) Tom
Baker Cancer Center, Calgary, Alberta, Canada.
Alberta
Cancer Board Scientific Retreat, 29th Nov – 1st Dec 1991;
Abstract
3.
FACTORS AFFECTING DISEASE-FREE
SURVIVAL (DFS) IN CANCER OF NASOPHARYNX, UNI AND MULTIVARIATE ANALYSIS. N. Jha (1), J.M. Nabholtz (1), M. Al-Ahwal
(1), E. Rapp (2), C. Smith (2), Head and Neck Oncology Group of Alberta (1)
Cross Cancer Institute, Edmonton, (2) Tom Baker Cancer Center, Calgary,
Alberta, canada. Alberta Cancer Board Scientific Retreat, 29th
Nov – 1st Dec 1991; Abstract.
4.
THE EFFECT OF METHYLPHENIDATE ( MP )
ON NARCOTIC INDUCED COGNITIVE FAILURE, M.
Al-Ahwal *, E. Buerura, T. Macchachrin.
Proceedings of the American Society of Clinical Oncology, Volume 11,
March 1992. Abstract No. 1385.
5.
SERUM INTERLEUKIN-6 ( IL-6 ) AND
C-REACTIVE PROTEIN ( CRP ) IN HEATSTROKE PATIENTS DURING PILGRIMAGE TO MAKKAH. I.A. Hashim, A. Al-Zeer, M. Al-Ahwal, S. Al-Shohaib and A. Shenkin.
Proceedings of the Annals of Clinical Biochemistry National Meeting, Glasgow, UK
1995; Abstract No. C55 Page 156.
6.
CANCER PATIENTS AWARENESS OF THEIR
DISEASE AND PROGNOSIS. M.S. Al-Ahwal. 13th
Asia Pacific Cancer Conference, 1996; Abstract
Page, 476.
7.
OLFACTORY NEUROBLASTOMA: REPORT OF A
CASE ASSOCIATED WITH INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION. M. Al-Ahwal*, N. Jha, J.M. Nabholtz, J. Hugh,
I. Birchall, G. K. Nguyen. The Journal of Otolaryngology, 1994; 6:437 –
439.
8.
CYTOKINE CHANGES IN PATIENTS WITH
HEATSROKE DURING PILGRIMAGE TOMAKKAH. I. A. Hashim (1), A. Al-Zeer 94), S.
Al-Shohaib (2), M. Al-Ahwal (3) and A. Shenkin (5). Mediators of Inflammation,
197; 6:135 – 139.
9.
CHEMOTHERAPY AND MYOCARDIAL ISCHEMIA. M. Al-Ahwal, P.
Venner. Asian Cardiovascular & Thoracic Annals, 1997; Volume 5, No. 4: 213
– 215.
10. CANCER
PATIENTS AWARENESS OF THEIR DISEASE AND PROGNOSIS. M. Al-Ahwal. Annals of Saudi Medicine, March
1998; Volume 18, No.2: 187 – 189.
11. CHEMOEMBOLIZATION
IN HEPATOCELLULAR CARCINOMA: KAUH EXPERIENCE. M. Al-Ahwal, M. Rawas, H. Akbar.
Saudi Medical Journal, 1998; Vol. 19(4): 479 – 482.
12. CHEMOEMBOLIZATION
IN METASTATIC LIVER NEOPLASMS: KAUH EXPERIENCE. M. Al-Ahwal, M.
Rawas, H. Akbar. Journal of King
AbdulAziz University
Medical Sciences 1999; Vol. 7(1): 109 – 114.
13.
FACTORS DELAYING THE
DIAGNOSIS OF CANCER IN CHILDREN. H Meir, H Nayel, MS Al-Ahwal, H
Al-Idrissi, H Meer, H Mair, A Ayoub, I El-Balawi, M Al-Mubarak. Medical Journal
of Cairo University, 2003; Vol. 71(2): 55 - 60.
14.
PARENTAL FACTORS IN
CHILDHOOD MALIGNANCIES. H Meir, H Nayel, MA Mohammed, E Al-Dalaan, MS
Al-Ahwal, H Al-Idrissi, H Mair, H Meer, A Ayoub, I El-Balawi, M Al-Mubarak.
Medical Journal of Cairo
University, 2003; Vol.
71(2): 87 - 94.
15.
CARCINOMA OF THE
NASOPHARYNX – THE EDMONTON
EXPERIENCE. N Jha, M Al Ahwal, J
Hanson. Current Oncology 2000; 7 (2): 110 – 114. (Co-Author).
16.
EFFECT OF PEG INTERFERON
ON NON-RESPONDERS AND RELAPSERS WITH INTERFERON. H. Akbar, M Al-Ahwal.
SQU Journal for Scientific Research: Medical Sciences 2002; 4(1-2): 9 -13. (Co-Author).
17.
SOCIAL ASSESSMENT OF CANCER PATIENTS
DURING THERAPY IN A SAUDI POPULATION. M Al-Ahwal. Emirates Medical Journal
2004; 22 (3): 245 - 247. (Single Author).
18.
QUALITY OF LIFE AFTER INTRAPERITONEAL
CHEMOTHERAPY FOR PERITONEAL CARCINOMATOSIS. M Al-Ahwal. Pakistan
Journal of Medical Sciences 2005; 21 (1): 22 – 25. (Single Author).
19.
Febrile Neutropenia Comparison between
solid tumors and hematological malignancies. M. Al-Ahwal, F. Al-Sayes, I. Jowhar. Pan Arab Medical Journal 2005; 2 (4): 4 -
7. (Main Author).
20.
HEALTH RELATED QUALITY OF LIFE
ASSESSMENT OF CANCER PATIENTS DURING CHEMOTHERAPY / RADIOTHERAPY AMONG SAUDI
POPULATION.
M Al-Ahwal. Journal of King
AbdulAziz University
Medical Sciences 2005; 12: 21- 31. (Single Author).
21.
MALGNANT ECCRINE POROMA, Case report
and review of the literature. M
Al-Ahwal, A. Sawan, S. Zimmo. Saudi Medical Journal 2005; 26 (5) 859
- 861. (Main Author).
22.
Age and Survival status of breast
cancer patients at two hospitals in the western region of Saudi Arabia. M. Al-Ahwal.
Pan Arab Medical Journal. Accepted for publication ( April 4th,
2005) (Single Author)
23.
PATTERN OF COLORECTAL CANCER AT TWO
HOSPITALS IN THE WESTERN REGION OF SAUDI ARABIA. M Al-Ahwal,
A Al-Ghamdi. SAUDI JOURNAL OF GASTROENTEROLOGY 2005; 11 (3) 156 - 161. (Main
Author).
24.
Distribution of risk factors in
patients with COLORECTAL CANCER in SAUDI Arabia. M Al-Ahwal,
A Al-Ghamdi. Qatar
Medical Journal 2006; 15 (1): 25 - 28. (Main Author).
25.
HER-2 Positivity and correlations with
other histopathologic features in breast cancerpatients, Hospital based study. M. Al-Ahwal.
Journal of Pakistan
Medical Association 2006; 56 (2): 65 - 68. (Single Author).
26.
Pattern of Febrile Neutropenia in
Solid Tumors, Hospital based study. M. Al-Ahwal. Pakistan
Journal of Medical Sciences 2005; 21 (3). (Single Author).
27.
PROTEASOME INHIBITOR NOVEL TREATMENT
IN MULTIPLE MYELOMA.
F Sayes, M Al-Ahwal. Mansoura Medical Journal 2005; 36 (1& 2): 199 –
212. (Co-Author).
28.
Awareness and attitude towards Cancer &
early detection program at KAUH in the western region of Saudi Arabia. M.
Al-Ahwal, A. Al-Ghamdi. Pan Arab Medical Journal 2006; 2 (7): 50 – 56. ( Main
Author ).